Stay updated with breaking news from Robertm Plenge. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Colton Groome Financial Advisors LLC lowered its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 5.5% in the 2nd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 3,394 shares of the biopharmaceutical company’s stock after selling 198 shares during the period. […]
Janney Montgomery Scott LLC lifted its stake in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 1.0% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 763,617 shares of the biopharmaceutical company’s stock after purchasing an additional 7,382 shares during the quarter. […]
Bristol-Myers Squibb (NYSE:BMY – Get Free Report)‘s stock had its “overweight” rating reaffirmed by analysts at Cantor Fitzgerald in a report released on Monday, Benzinga reports. They currently have a $75.00 price target on the biopharmaceutical company’s stock. Cantor Fitzgerald’s target price points to a potential upside of 34.02% from the stock’s previous close. BMY […]
Schmidt P J Investment Management Inc. lessened its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 3.6% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 21,595 shares of the biopharmaceutical company’s stock after selling 800 shares during the period. Schmidt P […]
Physicians Financial Services Inc. increased its position in shares of Bristol-Myers Squibb (NYSE:BMY – Free Report) by 4.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 17,288 shares of the biopharmaceutical company’s stock after acquiring an additional 784 shares […]